Major Research Areas

Selected Publications

Levchenko A, Mehta BM, Lee JB, Humm JL, Augensen F, Squire O, Kothari PJ, Finn RD, Leonard EF, Larson SM. Evaluation of 11C-colchicine for PET imaging of multiple drug resistance. J Nucl Med. 2000;41:493-501.

Fonti R, Levchenko A, Mehta BM, Zhang J, Tsuruo T, Larson SM. Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography. Nucl Med Biol. 1999;26:35-41.

Levchenko A, Mehta BM, Spengler BA, Narkar AA, Fonti R, Biedler JL, Tsuruo T, Larson SM. Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay. Anal Biochem. 1996;236:338-43.

Mehta BM, Levchenko A, Rosa E, Kim SW, Winnick S, Zhang JJ, Kalaigian H, Larson SM. Evaluation of carbon-14-colchicine biodistribution with whole-body quantitative autoradiography in colchicine-sensitive and -resistant xenografts. J Nucl Med. 1996;37:312-314.

Mehta BM, Rosa E, Biedler JL, Larson SM. In vivo uptake of carbon-14-colchicine for identification of tumor multidrug resistance. J Nucl Med. 1994;35:1179-84.

Mehta BM, Rosa E, Fissekis JD, Bading JR, Biedler JL, Larson SM. In-vivo identification of tumor multidrug resistance with 3H-colchicine [corrected]. J Nucl Med. 1992;33:1373-7. Erratum in: J Nucl Med 1992;33:1619.

Return to Noninvasive Diagnosis and Quantitation of Multi-drug Resistance by PET Main Page

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2008 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org